Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161797-99-5 Febuxostat Ma'ema'e Kūwaena >99.0% Hale Hana
ʻO Ruifu Chemical Supply Febuxostat Nā Kūwaena Pili:
Febuxostat CAS 144060-53-7
Ethyl 2-Chloroacetoacetate CAS 609-15-4
4-Hydroxythiobenzamide CAS 25984-63-8
Ethyl 2-(3-Cyano-4-Hydroxyphenyl)-4-Methyl-1,3-Thiazole-5-Carboxylate CAS 161798-02-3
Ethyl 2-(3-Cyano-4-Isobutoxyphenyl)-4-Methyl-5-Thiazolecarboxylate CAS 160844-75-7
Ethyl 2-(3-Formyl-4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161798-01-2
Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161798-03-4
Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161797-99-5
Inoa Kimia | Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate |
Nā huaʻōlelo like | ʻO Febuxostat Intermediate |
Helu CAS | 161797-99-5 |
Helu CAT | RF-PI1122 |
Kūlana Kūʻai | I loko o ka waihona, hana hiki ke hiki 100 tona / makahiki |
ʻĀpana Molekala | C13H13NO3S |
Kaumaha Molecular | 263.31 |
Lae hehee | 180 ℃ |
Brand | Kemika Ruifu |
'ikamu | Nā kikoʻī |
Ka nana aku | Melemele māmā i ka pauda keʻokeʻo |
ʻIkepili | Na HPLC;Na HNMR |
Nalo ma ka maloo | <0.50% |
Koena ma ka Ighition | <0.30% |
Hoʻokahi haumia | <0.50% |
Huina paumaele | <1.00% |
Maʻemaʻe / Kaʻina Hanana | >99.0% (na HPLC) |
Kūlana hoʻāʻo | ʻOihana Kūlana |
Hoʻohana | Waena o Febuxostat (CAS: 144060-53-7) |
Pūʻolo: ʻOmole, ʻeke ʻeke Aluminum, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.
Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai
Hoʻohana ʻia ʻo Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate (CAS: 161797-99-5) i ka synthesis o Febuxostat (CAS: 144060-53-7), he xanthine oxidase / xanthine dehydrogenase inhibitor.Hoʻohana ʻia no ka mālama ʻana i ka hyperuricemia a me ka gout mau.40-120 mg / lā febuxostat ua hōʻoia maikaʻi i ka hoʻohaʻahaʻa ʻana i nā pae serum urate ke lawelawe ʻia e mālama i ka hyperuricemia i nā maʻi me ka gout.Ua ʻike ʻia ʻo Fabuxostat e Teijin Pharmaceuticals a ua laikini ʻia iā TAP Pharmaceuticals (ʻo ia ka ʻāpana o Takeda Pharmaceuticals i kēia manawa) a ua ʻae ʻia i ka US no ka mālama ʻana i ka hyperuricemia i nā maʻi me ka gout.